The efficacy of a targeted PREVENTION programme for addictive behaviour (PREVENTURE) among vulnerable ADOlescents in France - study procotol.
Morgane Guillou-Landreat, Elkhan Tahmazov, Schreck Benoit...
https://pubmed.ncbi.nlm.nih.gov/33892682Actively Recruiting
Phase Not Applicable
Age: 14Years - 17Years
All Genders
ID04599270
Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) for Vulnerable Teenagers
Led by University Hospital, Brest · Updated on 2025-12-22
700
Participants Needed
5
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to evaluate the effectiveness of the PREVENTURE prevention program in reducing addictive behaviors among vulnerable teenagers aged 14 to 17. The study focuses on adolescents who have tried alcohol at least once and assesses personality traits linked to substance misuse risk. It addresses the need for effective primary prevention strategies outside school settings, as many existing programs show little impact on reducing substance use among teens. Participants complete the Substance Use Risk Profile Scale (SURPS) questionnaire to identify personality traits associated with risk for substance use. Those with at-risk traits are randomized into two groups: one group follows the PREVENTURE program, which consists of two 90-minute sessions delivered via videoconference, alongside routine care; the other group receives routine care alone. Follow-up contacts by phone occur at 1, 3, 6, and 12 months after the sessions or inclusion. Throughout the study, researchers assess substance use intensity, including alcohol, tobacco, and cannabis consumption, as well as anxiety, depression, alcohol-related harm, and quality of life at various time points up to 12 months. Adherence and acceptability of the program are also monitored via questionnaires during follow-up calls. The primary outcome measured is the occurrence of intensive punctual alcohol use at 6 months.
CONDITIONS
Brief Title
Efficiency of Prevention Program Dedicated to Addictive Behaviors (PREVENTURE) of Vulnerable Teenagers
Who Can Participate
Age: 14Years - 17Years
All Genders
Eligibility Criteria
You may qualify if you...
- Aged between 14 and 17 years old
- Consulting in one of the participating centers or referred by a school doctor
- Has had at least one previous experience with alcohol (at least 1 standard unit of alcohol, once in their lifetime)
- Has access to an internet connection and a computer, tablet, or telephone
- Written and informed consent from both the parents and the teenager
You will not qualify if you...
- Refusal to participate in the study
- Moderate to severe adolescent substance use disorders (other than smoking)
- Decompensated current psychiatric disorders
- Already receiving treatment for severe substance use or psychiatric disorders
- Does not understand the French language
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Intervention
Duration - Up to 3 months
Participants with at-risk personality traits will either follow the PREVENTURE program consisting of 2 sessions of 90 minutes by videoconference within 3 months after inclusion, or they will follow routine care.
2 sessions by videoconference for the intervention group; routine care for the control group
Follow-up
Duration - 12 months after intervention or inclusion
Participants will be contacted by phone at 1, 3, 6, and 12 months after the intervention or inclusion to complete assessments on substance use, alcohol consumption, tobacco consumption, cannabis consumption, anxiety, depression, alcohol-related harm, quality of life, and acceptability of the study.
4 phone contacts
Trial Site Locations
Total: 5 locations
1
Loik JOUSNI
Brest, France
Actively Recruiting
2
Morgane GUILLOU - LANDREAT
Brest, France
Actively Recruiting
3
Pascale ROZEC
Landerneau, France
Actively Recruiting
4
Catherine SIMON
Morlaix, France
Actively Recruiting
5
Benoit SCHRECK
Nantes, France
Actively Recruiting
Loading map...
Research Team
M
Morgane GUILLOU - LANDREAT, Dr
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here